The European Society for Medical Oncology (ESMO) has announced today that the recipient of the 2025 TAT Honorary Award is Philippe Bedard, Professor of Medicine at the University of Toronto, Staff Medical Oncologist in the Division of Medical Oncology, Director of the Cancer Genomics Program, and a Principal Investigator in the Bras Drug Development Program at the Princess Margaret Cancer Centre, in Toronto, Canada.
Philippe Bedard will deliver the Award lecture “Bridging cancer genomics and drug development: An academic perspective “on Monday, 3 March at the ESMO TAT Congress 2025 in Paris, France.